The report covers forecast and analysis for the contract research organization (CRO) market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based on revenue (USD billion). The study includes drivers and restraints for the contract research organization market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the contract research organization market on a global level.
In order to give the users of this report a comprehensive view on the contract research organization market, we have included a detailed buying criteria, product portfolio, competitive scenario, and analysis of key industry players. To understand the competitive landscape in the market, an analysis of Porter&rsquos Five Forces model for the contract research organization market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.
The study provides a decisive view on the contract research organization market by segmenting the market based on applications. All the end-user segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. Key end-user market covered under this study include early-stage development services and last-stage development services. The regional segmentation includes the current and forecast demand for Americas, EMEA (Europe, Middle East & Africa) and Asia Pacific with its further bifurcation into major countries including U.S., China, and India. This segmentation includes demand for contract research organization market based on individual applications in all the regions and countries.
This Report covered some of the key players involved globally in contract research organization market includes Covance, Parexel International, PRA Health Sciences, Quintiles Translational. Other prominent players in the contract research organization market includes Chiltern, Charles River Laboratories, Icon, Inventiv Health, QPS, Ricerca Biosciences, EPS , SynteractHCR, INC Research, WIL Research and WuXi AppTec.
Contract Research Organization Market &ndash End-user Analysis
Early-Stage Development Services
Last-Stage Development Services
Contract Research Organization Market - Regional Analysis
Americas
U.S.
Europe
Asia Pacific
China
India
Middle East and Africa
Table of Content
Chapter 1. Preface
1.1. Report description and scope
1.2. Research methodology
1.2.1. Market research process
1.2.2. Market research methodology
1.3. List of abbreviations
Chapter 2. Executive Summary
2.1. Global CRO Market Revenue, 2014 - 2020 (USD Billion)
2.2. Global Market: Snapshot
Chapter 3. CRO Market – Global Industry Analysis
3.1. Introduction
3.2. Market Drivers
3.2.1. Drivers for Global CRO Market: Impact Analysis
3.2.2. Rising Outsourcing of Research and Development
3.2.2.1. Comparison of Research Costs in US and India
3.2.3. Increase in Patent Expiries
3.2.3.1. Number of Drugs Going Off-patent 2013-2016
3.2.4. Emergence of CROs in Developing Countries
3.2.5. Increased Demand for Outsourced Services
3.2.6. Expansion of Product Portfolio
3.3. Market Restraints
3.3.1. Restraints for Global CRO Market: Impact Analysis
3.3.2. Shortage of Skilled Technicians
3.3.3. Clinical Trial Failures
3.3.3.1. Key Factors in Failure of Clinical Trials
3.3.4. Stringent Government Regulations
3.3.5. Reduced RD Budgets
3.4. Opportunity
3.4.1. Increase in MA
3.4.2. Increased RD by Biopharmaceutical Vendors
3.4.3. Increase in Strategic Alliances
3.4.4. Forward and Backward Integration by CROs
3.5. Porter’s Five Forces Analysis
3.6. Market Attractiveness Analysis
3.6.1. Market Attractiveness Analysis by End-user Segment
3.6.2. Market Attractiveness Analysis by Geography
Chapter 4. Global CRO Market – Competitive Landscape
4.1. Buying Criteria
4.2. Product Offerings
4.3. Competitive Scenario
4.3.1. Key News
4.3.2. Mergers and Acquisitions
4.4. Market Share Analysis 2014
4.4.1. Segmentation of Global CRO Market by Vendor 2014
4.4.1.1. Quintiles: Revenue by Business Segmentation 2013
4.4.1.2. PAREXEL: Business Segmentation, 2014
4.4.1.3. Market Share of Top Four CROs, 2014
4.5. Other Prominent Vendors
Chapter 5. Global CRO Market – End-user Segment Analysis
5.1. CRO Market: End-user Segment Analysis
5.1.1. Global CRO Market Share by End-user Segment, 2014 - 2020
5.2. Early-Stage Development Services
5.2.1. Global Early-Stage Development Services Market for CRO, 2014 - 2020, (USD Billion)
5.3. Last-Stage Development Services
5.3.1. Global CRO Market for Last-Stage Development Services, 2014 - 2020, (USD Billion)
5.4. Segmentation of Global CRO Market by Type of Activity 2014
Chapter 6. Global CRO Market – Therapeutic Area Analysis
6.1. Global CRO Market: Therapeutic Area Analysis
6.1.1. RD Clinical Trial Pipeline Exhibit 10: by Therapeutic Area 2014
Chapter 7. Global CRO Market – Geography Analysis
7.1. CRO Market: Geography Analysis
7.1.1. Global CRO Market Share by Geography, 2014 – 2020
7.2. North America
7.2.1. North America CRO Market, 2014 – 2020, (USD Billion)
7.3. Europe
7.3.1. Europe CRO Market, 2014 – 2020, (USD Billion)
7.4. Asia-Pacific
7.4.1. Asia-Pacific CRO Market, 2014 – 2020, (USD Billion)
7.5. China
7.5.1. China CRO Market, 2014 – 2020, (USD Billion)
7.6. India
7.6.1. India CRO Market, 2014 – 2020, (USD Billion)
7.7. Middle East and Africa
7.7.1. Middle East and Africa CRO Market, 2014 – 2020, (USD Billion)
Chapter 8. Company Profiles
8.1. Covance
8.1.1. Overview
8.1.2. Financials
8.1.3. Covance Revenue by Geography, 2013
8.1.4. Covance Revenue by Product Segment, 2013
8.1.5. Business Strategy
8.1.6. Recent Developments
8.1.7. SWOT Analysis
8.2. Parexel International
8.2.1. Overview
8.2.2. Financials
8.2.3. Parexel International Revenue by Geography, 2013
8.2.4. Strategy
8.2.5. Recent Developments
8.2.6. SWOT Analysis
8.3. PRA Health Sciences
8.3.1. Overview
8.3.2. Business Strategy
8.3.3. Recent Developments
8.3.4. SWOT Analysis
8.4. Quintiles
8.4.1. Overview
8.4.2. Financials
8.4.3. Quintiles Revenue by Geography, 2013
8.4.4. Quintiles Revenue by Segment, 2013
8.4.5. Recent Developments
8.4.6. SWOT Analysis
